nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoprolol—ABCB1—melanoma	0.536	1	CbGaD
Metoprolol—CYP2D6—Vemurafenib—melanoma	0.0603	0.483	CbGbCtD
Metoprolol—ABCB1—Dactinomycin—melanoma	0.0425	0.341	CbGbCtD
Metoprolol—ABCB1—Docetaxel—melanoma	0.022	0.176	CbGbCtD
Metoprolol—Amnesia—Temozolomide—melanoma	0.00135	0.00544	CcSEcCtD
Metoprolol—Menopausal symptoms—Temozolomide—melanoma	0.00135	0.00541	CcSEcCtD
Metoprolol—Liver function test abnormal—Dactinomycin—melanoma	0.0013	0.00521	CcSEcCtD
Metoprolol—Bronchospasm—Bleomycin—melanoma	0.00128	0.00515	CcSEcCtD
Metoprolol—Oropharyngeal pain—Docetaxel—melanoma	0.00128	0.00515	CcSEcCtD
Metoprolol—Arthralgia—Vemurafenib—melanoma	0.00127	0.00512	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00127	0.00509	CcSEcCtD
Metoprolol—Affect lability—Temozolomide—melanoma	0.00125	0.00503	CcSEcCtD
Metoprolol—Hearing impaired—Docetaxel—melanoma	0.00122	0.00492	CcSEcCtD
Metoprolol—Liver function test abnormal—Carmustine—melanoma	0.00121	0.00488	CcSEcCtD
Metoprolol—Mood swings—Temozolomide—melanoma	0.0012	0.00484	CcSEcCtD
Metoprolol—Nervous system disorder—Vemurafenib—melanoma	0.0012	0.00482	CcSEcCtD
Metoprolol—Skin disorder—Vemurafenib—melanoma	0.00119	0.00477	CcSEcCtD
Metoprolol—Pneumonia—Bleomycin—melanoma	0.00117	0.00469	CcSEcCtD
Metoprolol—Breast disorder—Temozolomide—melanoma	0.00115	0.00462	CcSEcCtD
Metoprolol—Hypotension—Vemurafenib—melanoma	0.00114	0.00459	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00111	0.00448	CcSEcCtD
Metoprolol—Pneumonia—Dactinomycin—melanoma	0.00109	0.00438	CcSEcCtD
Metoprolol—Sweating increased—Temozolomide—melanoma	0.00107	0.0043	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Vemurafenib—melanoma	0.00106	0.00424	CcSEcCtD
Metoprolol—Fatigue—Vemurafenib—melanoma	0.00105	0.00424	CcSEcCtD
Metoprolol—Constipation—Vemurafenib—melanoma	0.00105	0.0042	CcSEcCtD
Metoprolol—Lightheadedness—Docetaxel—melanoma	0.00104	0.00419	CcSEcCtD
Metoprolol—Pneumonia—Carmustine—melanoma	0.00102	0.0041	CcSEcCtD
Metoprolol—Erectile dysfunction—Temozolomide—melanoma	0.00101	0.00407	CcSEcCtD
Metoprolol—Depression—Carmustine—melanoma	0.00101	0.00406	CcSEcCtD
Metoprolol—Agranulocytosis—Dactinomycin—melanoma	0.00101	0.00406	CcSEcCtD
Metoprolol—Photosensitivity reaction—Temozolomide—melanoma	0.001	0.00403	CcSEcCtD
Metoprolol—Weight increased—Temozolomide—melanoma	0.001	0.00402	CcSEcCtD
Metoprolol—Pneumonia—Temozolomide—melanoma	0.000985	0.00396	CcSEcCtD
Metoprolol—Depression—Temozolomide—melanoma	0.000977	0.00392	CcSEcCtD
Metoprolol—Hepatitis—Dactinomycin—melanoma	0.000972	0.00391	CcSEcCtD
Metoprolol—Body temperature increased—Vemurafenib—melanoma	0.000966	0.00388	CcSEcCtD
Metoprolol—Deafness—Docetaxel—melanoma	0.000945	0.0038	CcSEcCtD
Metoprolol—Cardiac failure congestive—Docetaxel—melanoma	0.000932	0.00375	CcSEcCtD
Metoprolol—Hepatobiliary disease—Temozolomide—melanoma	0.000926	0.00372	CcSEcCtD
Metoprolol—Alopecia—Bleomycin—melanoma	0.000921	0.0037	CcSEcCtD
Metoprolol—Hallucination—Carmustine—melanoma	0.000905	0.00364	CcSEcCtD
Metoprolol—Hot flush—Docetaxel—melanoma	0.000903	0.00363	CcSEcCtD
Metoprolol—Hypersensitivity—Vemurafenib—melanoma	0.0009	0.00362	CcSEcCtD
Metoprolol—Oedema peripheral—Carmustine—melanoma	0.000896	0.0036	CcSEcCtD
Metoprolol—Menopausal symptoms—Docetaxel—melanoma	0.000896	0.0036	CcSEcCtD
Metoprolol—Connective tissue disorder—Carmustine—melanoma	0.000894	0.00359	CcSEcCtD
Metoprolol—Visual disturbance—Docetaxel—melanoma	0.000892	0.00358	CcSEcCtD
Metoprolol—Hepatitis—Temozolomide—melanoma	0.000879	0.00353	CcSEcCtD
Metoprolol—Asthenia—Vemurafenib—melanoma	0.000877	0.00352	CcSEcCtD
Metoprolol—Visual impairment—Carmustine—melanoma	0.000877	0.00352	CcSEcCtD
Metoprolol—Hallucination—Temozolomide—melanoma	0.000875	0.00352	CcSEcCtD
Metoprolol—Oedema peripheral—Temozolomide—melanoma	0.000866	0.00348	CcSEcCtD
Metoprolol—Cardiac failure—Docetaxel—melanoma	0.000866	0.00348	CcSEcCtD
Metoprolol—Pruritus—Vemurafenib—melanoma	0.000865	0.00348	CcSEcCtD
Metoprolol—Connective tissue disorder—Temozolomide—melanoma	0.000864	0.00347	CcSEcCtD
Metoprolol—Alopecia—Dactinomycin—melanoma	0.000859	0.00345	CcSEcCtD
Metoprolol—Eye disorder—Carmustine—melanoma	0.00085	0.00342	CcSEcCtD
Metoprolol—Visual impairment—Temozolomide—melanoma	0.000847	0.00341	CcSEcCtD
Metoprolol—Diarrhoea—Vemurafenib—melanoma	0.000836	0.00336	CcSEcCtD
Metoprolol—Eye disorder—Temozolomide—melanoma	0.000822	0.0033	CcSEcCtD
Metoprolol—Tinnitus—Temozolomide—melanoma	0.00082	0.00329	CcSEcCtD
Metoprolol—Cardiac disorder—Temozolomide—melanoma	0.000816	0.00328	CcSEcCtD
Metoprolol—Arrhythmia—Carmustine—melanoma	0.000813	0.00327	CcSEcCtD
Metoprolol—Leukopenia—Bleomycin—melanoma	0.000812	0.00326	CcSEcCtD
Metoprolol—Dizziness—Vemurafenib—melanoma	0.000808	0.00325	CcSEcCtD
Metoprolol—Alopecia—Carmustine—melanoma	0.000804	0.00323	CcSEcCtD
Metoprolol—Angiopathy—Temozolomide—melanoma	0.000798	0.00321	CcSEcCtD
Metoprolol—Mental disorder—Carmustine—melanoma	0.000797	0.0032	CcSEcCtD
Metoprolol—Immune system disorder—Temozolomide—melanoma	0.000794	0.00319	CcSEcCtD
Metoprolol—Mediastinal disorder—Temozolomide—melanoma	0.000792	0.00318	CcSEcCtD
Metoprolol—Liver function test abnormal—Docetaxel—melanoma	0.00078	0.00314	CcSEcCtD
Metoprolol—Vomiting—Vemurafenib—melanoma	0.000777	0.00312	CcSEcCtD
Metoprolol—Alopecia—Temozolomide—melanoma	0.000777	0.00312	CcSEcCtD
Metoprolol—Chest pain—Bleomycin—melanoma	0.000772	0.0031	CcSEcCtD
Metoprolol—Abdominal pain upper—Docetaxel—melanoma	0.000772	0.0031	CcSEcCtD
Metoprolol—Orthostatic hypotension—Docetaxel—melanoma	0.000772	0.0031	CcSEcCtD
Metoprolol—Rash—Vemurafenib—melanoma	0.000771	0.0031	CcSEcCtD
Metoprolol—Mental disorder—Temozolomide—melanoma	0.00077	0.0031	CcSEcCtD
Metoprolol—Dermatitis—Vemurafenib—melanoma	0.00077	0.00309	CcSEcCtD
Metoprolol—Headache—Vemurafenib—melanoma	0.000766	0.00308	CcSEcCtD
Metoprolol—Breast disorder—Docetaxel—melanoma	0.000764	0.00307	CcSEcCtD
Metoprolol—Cramp muscle—Docetaxel—melanoma	0.000761	0.00306	CcSEcCtD
Metoprolol—Leukopenia—Dactinomycin—melanoma	0.000757	0.00304	CcSEcCtD
Metoprolol—Dysgeusia—Temozolomide—melanoma	0.000749	0.00301	CcSEcCtD
Metoprolol—Confusional state—Bleomycin—melanoma	0.000747	0.003	CcSEcCtD
Metoprolol—Vision blurred—Carmustine—melanoma	0.000746	0.003	CcSEcCtD
Metoprolol—Oedema—Bleomycin—melanoma	0.00074	0.00298	CcSEcCtD
Metoprolol—Nausea—Vemurafenib—melanoma	0.000726	0.00292	CcSEcCtD
Metoprolol—Thrombocytopenia—Bleomycin—melanoma	0.000725	0.00291	CcSEcCtD
Metoprolol—Vision blurred—Temozolomide—melanoma	0.000721	0.0029	CcSEcCtD
Metoprolol—Bronchospasm—Docetaxel—melanoma	0.000719	0.00289	CcSEcCtD
Metoprolol—Angina pectoris—Docetaxel—melanoma	0.000712	0.00286	CcSEcCtD
Metoprolol—Leukopenia—Carmustine—melanoma	0.000709	0.00285	CcSEcCtD
Metoprolol—Hypotension—Bleomycin—melanoma	0.000692	0.00278	CcSEcCtD
Metoprolol—Oedema—Dactinomycin—melanoma	0.000691	0.00278	CcSEcCtD
Metoprolol—Vertigo—Temozolomide—melanoma	0.000688	0.00276	CcSEcCtD
Metoprolol—Leukopenia—Temozolomide—melanoma	0.000685	0.00275	CcSEcCtD
Metoprolol—Hypertension—Carmustine—melanoma	0.000684	0.00275	CcSEcCtD
Metoprolol—Palpitations—Temozolomide—melanoma	0.000676	0.00272	CcSEcCtD
Metoprolol—Thrombocytopenia—Dactinomycin—melanoma	0.000676	0.00272	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Bleomycin—melanoma	0.000675	0.00271	CcSEcCtD
Metoprolol—Chest pain—Carmustine—melanoma	0.000674	0.00271	CcSEcCtD
Metoprolol—Anxiety—Carmustine—melanoma	0.000672	0.0027	CcSEcCtD
Metoprolol—Paraesthesia—Bleomycin—melanoma	0.000665	0.00267	CcSEcCtD
Metoprolol—Weight increased—Docetaxel—melanoma	0.000665	0.00267	CcSEcCtD
Metoprolol—Hypertension—Temozolomide—melanoma	0.000661	0.00266	CcSEcCtD
Metoprolol—Dyspnoea—Bleomycin—melanoma	0.00066	0.00265	CcSEcCtD
Metoprolol—Pneumonia—Docetaxel—melanoma	0.000655	0.00263	CcSEcCtD
Metoprolol—Confusional state—Carmustine—melanoma	0.000652	0.00262	CcSEcCtD
Metoprolol—Arthralgia—Temozolomide—melanoma	0.000652	0.00262	CcSEcCtD
Metoprolol—Anxiety—Temozolomide—melanoma	0.000649	0.00261	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000647	0.0026	CcSEcCtD
Metoprolol—Oedema—Carmustine—melanoma	0.000646	0.0026	CcSEcCtD
Metoprolol—Dry mouth—Temozolomide—melanoma	0.000637	0.00256	CcSEcCtD
Metoprolol—Jaundice—Docetaxel—melanoma	0.000635	0.00255	CcSEcCtD
Metoprolol—Pain—Bleomycin—melanoma	0.000633	0.00254	CcSEcCtD
Metoprolol—Conjunctivitis—Docetaxel—melanoma	0.000633	0.00254	CcSEcCtD
Metoprolol—Thrombocytopenia—Carmustine—melanoma	0.000633	0.00254	CcSEcCtD
Metoprolol—Tachycardia—Carmustine—melanoma	0.000631	0.00254	CcSEcCtD
Metoprolol—Confusional state—Temozolomide—melanoma	0.00063	0.00253	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000629	0.00253	CcSEcCtD
Metoprolol—Oedema—Temozolomide—melanoma	0.000625	0.00251	CcSEcCtD
Metoprolol—Hepatobiliary disease—Docetaxel—melanoma	0.000616	0.00248	CcSEcCtD
Metoprolol—Nervous system disorder—Temozolomide—melanoma	0.000613	0.00246	CcSEcCtD
Metoprolol—Thrombocytopenia—Temozolomide—melanoma	0.000612	0.00246	CcSEcCtD
Metoprolol—Feeling abnormal—Bleomycin—melanoma	0.00061	0.00245	CcSEcCtD
Metoprolol—Agranulocytosis—Docetaxel—melanoma	0.000608	0.00244	CcSEcCtD
Metoprolol—Skin disorder—Temozolomide—melanoma	0.000607	0.00244	CcSEcCtD
Metoprolol—Hypotension—Carmustine—melanoma	0.000604	0.00243	CcSEcCtD
Metoprolol—Hyperhidrosis—Temozolomide—melanoma	0.000604	0.00243	CcSEcCtD
Metoprolol—Fatigue—Dactinomycin—melanoma	0.000595	0.00239	CcSEcCtD
Metoprolol—Pain—Dactinomycin—melanoma	0.000591	0.00237	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Carmustine—melanoma	0.000589	0.00237	CcSEcCtD
Metoprolol—Urticaria—Bleomycin—melanoma	0.000588	0.00236	CcSEcCtD
Metoprolol—Rhinitis—Docetaxel—melanoma	0.000586	0.00236	CcSEcCtD
Metoprolol—Body temperature increased—Bleomycin—melanoma	0.000585	0.00235	CcSEcCtD
Metoprolol—Hepatitis—Docetaxel—melanoma	0.000585	0.00235	CcSEcCtD
Metoprolol—Insomnia—Carmustine—melanoma	0.000585	0.00235	CcSEcCtD
Metoprolol—Paraesthesia—Carmustine—melanoma	0.00058	0.00233	CcSEcCtD
Metoprolol—Dyspnoea—Carmustine—melanoma	0.000576	0.00232	CcSEcCtD
Metoprolol—Oedema peripheral—Docetaxel—melanoma	0.000576	0.00231	CcSEcCtD
Metoprolol—Somnolence—Carmustine—melanoma	0.000575	0.00231	CcSEcCtD
Metoprolol—Connective tissue disorder—Docetaxel—melanoma	0.000575	0.00231	CcSEcCtD
Metoprolol—Feeling abnormal—Dactinomycin—melanoma	0.000569	0.00229	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Temozolomide—melanoma	0.000569	0.00229	CcSEcCtD
Metoprolol—Insomnia—Temozolomide—melanoma	0.000565	0.00227	CcSEcCtD
Metoprolol—Gastrointestinal pain—Dactinomycin—melanoma	0.000565	0.00227	CcSEcCtD
Metoprolol—Visual impairment—Docetaxel—melanoma	0.000563	0.00226	CcSEcCtD
Metoprolol—Paraesthesia—Temozolomide—melanoma	0.000561	0.00225	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Carmustine—melanoma	0.000558	0.00224	CcSEcCtD
Metoprolol—Dyspnoea—Temozolomide—melanoma	0.000557	0.00224	CcSEcCtD
Metoprolol—Somnolence—Temozolomide—melanoma	0.000555	0.00223	CcSEcCtD
Metoprolol—Constipation—Carmustine—melanoma	0.000553	0.00222	CcSEcCtD
Metoprolol—Pain—Carmustine—melanoma	0.000553	0.00222	CcSEcCtD
Metoprolol—Dyspepsia—Temozolomide—melanoma	0.00055	0.00221	CcSEcCtD
Metoprolol—Eye disorder—Docetaxel—melanoma	0.000546	0.0022	CcSEcCtD
Metoprolol—Abdominal pain—Dactinomycin—melanoma	0.000546	0.00219	CcSEcCtD
Metoprolol—Body temperature increased—Dactinomycin—melanoma	0.000546	0.00219	CcSEcCtD
Metoprolol—Hypersensitivity—Bleomycin—melanoma	0.000546	0.00219	CcSEcCtD
Metoprolol—Cardiac disorder—Docetaxel—melanoma	0.000543	0.00218	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Temozolomide—melanoma	0.000539	0.00217	CcSEcCtD
Metoprolol—Fatigue—Temozolomide—melanoma	0.000539	0.00216	CcSEcCtD
Metoprolol—Pain—Temozolomide—melanoma	0.000534	0.00215	CcSEcCtD
Metoprolol—Constipation—Temozolomide—melanoma	0.000534	0.00215	CcSEcCtD
Metoprolol—Feeling abnormal—Carmustine—melanoma	0.000533	0.00214	CcSEcCtD
Metoprolol—Asthenia—Bleomycin—melanoma	0.000531	0.00214	CcSEcCtD
Metoprolol—Angiopathy—Docetaxel—melanoma	0.00053	0.00213	CcSEcCtD
Metoprolol—Gastrointestinal pain—Carmustine—melanoma	0.000529	0.00212	CcSEcCtD
Metoprolol—Immune system disorder—Docetaxel—melanoma	0.000528	0.00212	CcSEcCtD
Metoprolol—Mediastinal disorder—Docetaxel—melanoma	0.000527	0.00212	CcSEcCtD
Metoprolol—Pruritus—Bleomycin—melanoma	0.000524	0.00211	CcSEcCtD
Metoprolol—Arrhythmia—Docetaxel—melanoma	0.000522	0.0021	CcSEcCtD
Metoprolol—Alopecia—Docetaxel—melanoma	0.000517	0.00208	CcSEcCtD
Metoprolol—Feeling abnormal—Temozolomide—melanoma	0.000515	0.00207	CcSEcCtD
Metoprolol—Mental disorder—Docetaxel—melanoma	0.000512	0.00206	CcSEcCtD
Metoprolol—Abdominal pain—Carmustine—melanoma	0.000511	0.00205	CcSEcCtD
Metoprolol—Body temperature increased—Carmustine—melanoma	0.000511	0.00205	CcSEcCtD
Metoprolol—Gastrointestinal pain—Temozolomide—melanoma	0.000511	0.00205	CcSEcCtD
Metoprolol—Hypersensitivity—Dactinomycin—melanoma	0.000509	0.00204	CcSEcCtD
Metoprolol—Dysgeusia—Docetaxel—melanoma	0.000498	0.002	CcSEcCtD
Metoprolol—Urticaria—Temozolomide—melanoma	0.000496	0.00199	CcSEcCtD
Metoprolol—Asthenia—Dactinomycin—melanoma	0.000495	0.00199	CcSEcCtD
Metoprolol—Abdominal pain—Temozolomide—melanoma	0.000494	0.00198	CcSEcCtD
Metoprolol—Body temperature increased—Temozolomide—melanoma	0.000494	0.00198	CcSEcCtD
Metoprolol—Muscle spasms—Docetaxel—melanoma	0.000489	0.00197	CcSEcCtD
Metoprolol—Hypersensitivity—Carmustine—melanoma	0.000476	0.00191	CcSEcCtD
Metoprolol—Diarrhoea—Dactinomycin—melanoma	0.000473	0.0019	CcSEcCtD
Metoprolol—Vomiting—Bleomycin—melanoma	0.000471	0.00189	CcSEcCtD
Metoprolol—Rash—Bleomycin—melanoma	0.000467	0.00188	CcSEcCtD
Metoprolol—Dermatitis—Bleomycin—melanoma	0.000466	0.00187	CcSEcCtD
Metoprolol—Asthenia—Carmustine—melanoma	0.000464	0.00186	CcSEcCtD
Metoprolol—Hypersensitivity—Temozolomide—melanoma	0.00046	0.00185	CcSEcCtD
Metoprolol—Syncope—Docetaxel—melanoma	0.000456	0.00183	CcSEcCtD
Metoprolol—Leukopenia—Docetaxel—melanoma	0.000456	0.00183	CcSEcCtD
Metoprolol—Palpitations—Docetaxel—melanoma	0.00045	0.00181	CcSEcCtD
Metoprolol—Asthenia—Temozolomide—melanoma	0.000448	0.0018	CcSEcCtD
Metoprolol—Loss of consciousness—Docetaxel—melanoma	0.000447	0.0018	CcSEcCtD
Metoprolol—Diarrhoea—Carmustine—melanoma	0.000442	0.00178	CcSEcCtD
Metoprolol—Pruritus—Temozolomide—melanoma	0.000442	0.00178	CcSEcCtD
Metoprolol—Nausea—Bleomycin—melanoma	0.00044	0.00177	CcSEcCtD
Metoprolol—Hypertension—Docetaxel—melanoma	0.000439	0.00177	CcSEcCtD
Metoprolol—Vomiting—Dactinomycin—melanoma	0.000439	0.00176	CcSEcCtD
Metoprolol—Rash—Dactinomycin—melanoma	0.000435	0.00175	CcSEcCtD
Metoprolol—Arthralgia—Docetaxel—melanoma	0.000433	0.00174	CcSEcCtD
Metoprolol—Chest pain—Docetaxel—melanoma	0.000433	0.00174	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.00043	0.00173	CcSEcCtD
Metoprolol—Dizziness—Carmustine—melanoma	0.000427	0.00172	CcSEcCtD
Metoprolol—Diarrhoea—Temozolomide—melanoma	0.000427	0.00172	CcSEcCtD
Metoprolol—Dry mouth—Docetaxel—melanoma	0.000424	0.0017	CcSEcCtD
Metoprolol—Confusional state—Docetaxel—melanoma	0.000419	0.00168	CcSEcCtD
Metoprolol—Oedema—Docetaxel—melanoma	0.000415	0.00167	CcSEcCtD
Metoprolol—Dizziness—Temozolomide—melanoma	0.000413	0.00166	CcSEcCtD
Metoprolol—Vomiting—Carmustine—melanoma	0.000411	0.00165	CcSEcCtD
Metoprolol—Nausea—Dactinomycin—melanoma	0.00041	0.00165	CcSEcCtD
Metoprolol—Shock—Docetaxel—melanoma	0.000409	0.00164	CcSEcCtD
Metoprolol—Rash—Carmustine—melanoma	0.000408	0.00164	CcSEcCtD
Metoprolol—Nervous system disorder—Docetaxel—melanoma	0.000407	0.00164	CcSEcCtD
Metoprolol—Dermatitis—Carmustine—melanoma	0.000407	0.00164	CcSEcCtD
Metoprolol—Thrombocytopenia—Docetaxel—melanoma	0.000407	0.00163	CcSEcCtD
Metoprolol—Tachycardia—Docetaxel—melanoma	0.000405	0.00163	CcSEcCtD
Metoprolol—Headache—Carmustine—melanoma	0.000405	0.00163	CcSEcCtD
Metoprolol—Skin disorder—Docetaxel—melanoma	0.000403	0.00162	CcSEcCtD
Metoprolol—Vomiting—Temozolomide—melanoma	0.000397	0.0016	CcSEcCtD
Metoprolol—Rash—Temozolomide—melanoma	0.000394	0.00158	CcSEcCtD
Metoprolol—Dermatitis—Temozolomide—melanoma	0.000393	0.00158	CcSEcCtD
Metoprolol—Headache—Temozolomide—melanoma	0.000391	0.00157	CcSEcCtD
Metoprolol—Hypotension—Docetaxel—melanoma	0.000388	0.00156	CcSEcCtD
Metoprolol—Nausea—Carmustine—melanoma	0.000384	0.00154	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Docetaxel—melanoma	0.000378	0.00152	CcSEcCtD
Metoprolol—Insomnia—Docetaxel—melanoma	0.000376	0.00151	CcSEcCtD
Metoprolol—Paraesthesia—Docetaxel—melanoma	0.000373	0.0015	CcSEcCtD
Metoprolol—Nausea—Temozolomide—melanoma	0.000371	0.00149	CcSEcCtD
Metoprolol—Dyspnoea—Docetaxel—melanoma	0.00037	0.00149	CcSEcCtD
Metoprolol—Somnolence—Docetaxel—melanoma	0.000369	0.00148	CcSEcCtD
Metoprolol—Dyspepsia—Docetaxel—melanoma	0.000366	0.00147	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Docetaxel—melanoma	0.000359	0.00144	CcSEcCtD
Metoprolol—Fatigue—Docetaxel—melanoma	0.000358	0.00144	CcSEcCtD
Metoprolol—Constipation—Docetaxel—melanoma	0.000355	0.00143	CcSEcCtD
Metoprolol—Pain—Docetaxel—melanoma	0.000355	0.00143	CcSEcCtD
Metoprolol—Feeling abnormal—Docetaxel—melanoma	0.000342	0.00138	CcSEcCtD
Metoprolol—Gastrointestinal pain—Docetaxel—melanoma	0.00034	0.00137	CcSEcCtD
Metoprolol—Abdominal pain—Docetaxel—melanoma	0.000328	0.00132	CcSEcCtD
Metoprolol—Body temperature increased—Docetaxel—melanoma	0.000328	0.00132	CcSEcCtD
Metoprolol—Hypersensitivity—Docetaxel—melanoma	0.000306	0.00123	CcSEcCtD
Metoprolol—Asthenia—Docetaxel—melanoma	0.000298	0.0012	CcSEcCtD
Metoprolol—Pruritus—Docetaxel—melanoma	0.000294	0.00118	CcSEcCtD
Metoprolol—Diarrhoea—Docetaxel—melanoma	0.000284	0.00114	CcSEcCtD
Metoprolol—Dizziness—Docetaxel—melanoma	0.000275	0.0011	CcSEcCtD
Metoprolol—Vomiting—Docetaxel—melanoma	0.000264	0.00106	CcSEcCtD
Metoprolol—Rash—Docetaxel—melanoma	0.000262	0.00105	CcSEcCtD
Metoprolol—Dermatitis—Docetaxel—melanoma	0.000262	0.00105	CcSEcCtD
Metoprolol—Headache—Docetaxel—melanoma	0.00026	0.00105	CcSEcCtD
Metoprolol—Nausea—Docetaxel—melanoma	0.000247	0.000992	CcSEcCtD
Metoprolol—Chlorphenesin—PTGS2—melanoma	0.000199	0.337	CrCbGaD
Metoprolol—Atenolol—ABCB1—melanoma	0.000169	0.286	CrCbGaD
Metoprolol—Acebutolol—ABCB1—melanoma	0.000156	0.264	CrCbGaD
Metoprolol—Propranolol—ABCB1—melanoma	6.65e-05	0.113	CrCbGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	2.75e-05	0.000308	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	2.73e-05	0.000305	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—PIK3CG—melanoma	2.72e-05	0.000304	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PLA2G6—melanoma	2.7e-05	0.000302	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—PIK3CG—melanoma	2.66e-05	0.000297	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—SYK—melanoma	2.65e-05	0.000296	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PLA2G6—melanoma	2.64e-05	0.000295	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—PIK3CD—melanoma	2.63e-05	0.000294	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—AKT3—melanoma	2.6e-05	0.000291	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—ITGAV—melanoma	2.6e-05	0.000291	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—NGFR—melanoma	2.6e-05	0.000291	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—SYK—melanoma	2.59e-05	0.00029	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—PIK3CD—melanoma	2.57e-05	0.000288	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—AKT3—melanoma	2.55e-05	0.000285	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—NGFR—melanoma	2.55e-05	0.000285	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—ITGAV—melanoma	2.55e-05	0.000285	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—ABCB1—melanoma	2.53e-05	0.000283	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	2.51e-05	0.00028	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PLA2G6—melanoma	2.48e-05	0.000278	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—VCAN—melanoma	2.43e-05	0.000271	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	2.43e-05	0.000271	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—SOCS1—melanoma	2.41e-05	0.000269	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—MAP2K1—melanoma	2.4e-05	0.000269	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—S100B—melanoma	2.4e-05	0.000269	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—PIK3CD—melanoma	2.39e-05	0.000267	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—VCAN—melanoma	2.37e-05	0.000265	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—SOCS1—melanoma	2.36e-05	0.000264	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—MAP2K1—melanoma	2.35e-05	0.000263	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—S100B—melanoma	2.35e-05	0.000263	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—PIK3CD—melanoma	2.34e-05	0.000261	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PRKCA—melanoma	2.33e-05	0.000261	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—ERCC2—melanoma	2.31e-05	0.000259	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—ERBB4—melanoma	2.3e-05	0.000257	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	2.3e-05	0.000257	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—PIK3CB—melanoma	2.29e-05	0.000256	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CDKN2B—melanoma	2.28e-05	0.000255	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—ERBB4—melanoma	2.25e-05	0.000251	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—PIK3CB—melanoma	2.24e-05	0.000251	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—VCAN—melanoma	2.23e-05	0.000249	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CDKN2B—melanoma	2.23e-05	0.000249	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—melanoma	2.22e-05	0.000248	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CD86—melanoma	2.2e-05	0.000246	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—CXCL8—melanoma	2.2e-05	0.000246	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—EDN1—melanoma	2.19e-05	0.000245	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CD86—melanoma	2.16e-05	0.000241	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—CXCL8—melanoma	2.16e-05	0.000241	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—EDN1—melanoma	2.14e-05	0.000239	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CSF2—melanoma	2.14e-05	0.000239	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—FGF1—melanoma	2.14e-05	0.000239	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—IL2—melanoma	2.11e-05	0.000235	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—E2F1—melanoma	2.09e-05	0.000234	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CSF2—melanoma	2.09e-05	0.000234	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—FGF1—melanoma	2.09e-05	0.000234	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—PIK3CB—melanoma	2.08e-05	0.000233	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PDGFRA—melanoma	2.07e-05	0.000231	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—IL2—melanoma	2.06e-05	0.00023	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—ITGB3—melanoma	2.05e-05	0.000229	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PRKCA—melanoma	2.05e-05	0.000229	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	2.05e-05	0.000229	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CYP17A1—melanoma	2.05e-05	0.000229	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—E2F1—melanoma	2.05e-05	0.000229	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—PIK3CB—melanoma	2.04e-05	0.000228	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PDGFRA—melanoma	2.03e-05	0.000226	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.02e-05	0.000226	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—SPP1—melanoma	2.01e-05	0.000225	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PRKCA—melanoma	2e-05	0.000224	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—ITGB3—melanoma	2e-05	0.000224	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—MAP2K2—melanoma	2e-05	0.000224	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—CXCL8—melanoma	2e-05	0.000224	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CYP17A1—melanoma	2e-05	0.000223	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—melanoma	1.99e-05	0.000223	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—SPP1—melanoma	1.97e-05	0.00022	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—MAP2K2—melanoma	1.96e-05	0.000219	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—CXCL8—melanoma	1.96e-05	0.000219	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—GNA11—melanoma	1.93e-05	0.000216	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—IL2—melanoma	1.91e-05	0.000214	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—TERT—melanoma	1.91e-05	0.000213	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—RAC1—melanoma	1.9e-05	0.000212	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—FASN—melanoma	1.89e-05	0.000211	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—GNA11—melanoma	1.89e-05	0.000211	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CYP17A1—melanoma	1.88e-05	0.00021	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—IL2—melanoma	1.87e-05	0.000209	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—TERT—melanoma	1.86e-05	0.000208	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—SLC5A5—melanoma	1.86e-05	0.000208	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—RAC1—melanoma	1.86e-05	0.000208	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	1.85e-05	0.000207	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—FASN—melanoma	1.85e-05	0.000206	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PIK3CG—melanoma	1.83e-05	0.000204	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—HIF1A—melanoma	1.82e-05	0.000204	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—SLC5A5—melanoma	1.82e-05	0.000203	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CD44—melanoma	1.8e-05	0.000201	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—GNAQ—melanoma	1.8e-05	0.000201	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—HIF1A—melanoma	1.78e-05	0.000199	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GNA11—melanoma	1.78e-05	0.000199	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PPARG—melanoma	1.76e-05	0.000197	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.76e-05	0.000197	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—GNAQ—melanoma	1.75e-05	0.000196	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CD44—melanoma	1.75e-05	0.000196	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.74e-05	0.000195	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—KDR—melanoma	1.74e-05	0.000195	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—FASN—melanoma	1.74e-05	0.000194	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CYP1B1—melanoma	1.72e-05	0.000193	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—SLC5A5—melanoma	1.71e-05	0.000191	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—KDR—melanoma	1.7e-05	0.000191	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CYP1B1—melanoma	1.68e-05	0.000188	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—FN1—melanoma	1.68e-05	0.000188	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GNAQ—melanoma	1.65e-05	0.000185	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CD44—melanoma	1.65e-05	0.000185	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—NOTCH1—melanoma	1.64e-05	0.000184	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—FN1—melanoma	1.64e-05	0.000183	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CD80—melanoma	1.61e-05	0.00018	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PIK3CD—melanoma	1.61e-05	0.00018	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—NOTCH1—melanoma	1.61e-05	0.00018	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—KIT—melanoma	1.61e-05	0.000179	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—APC—melanoma	1.61e-05	0.000179	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PIK3CG—melanoma	1.61e-05	0.000179	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—NRAS—melanoma	1.61e-05	0.000179	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—EGF—melanoma	1.59e-05	0.000177	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—ALB—melanoma	1.59e-05	0.000177	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CYP1B1—melanoma	1.58e-05	0.000177	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CD80—melanoma	1.57e-05	0.000176	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—KIT—melanoma	1.57e-05	0.000176	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PIK3CG—melanoma	1.57e-05	0.000176	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—APC—melanoma	1.57e-05	0.000176	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—NRAS—melanoma	1.57e-05	0.000176	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—EGF—melanoma	1.55e-05	0.000174	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—MAPK3—melanoma	1.54e-05	0.000172	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.52e-05	0.00017	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—BRAF—melanoma	1.51e-05	0.000169	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—MAPK3—melanoma	1.5e-05	0.000168	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—BRAF—melanoma	1.48e-05	0.000165	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—IGF1—melanoma	1.47e-05	0.000164	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—MAPK1—melanoma	1.46e-05	0.000164	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—EGFR—melanoma	1.46e-05	0.000163	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—IGF1—melanoma	1.44e-05	0.000161	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—MAPK1—melanoma	1.43e-05	0.00016	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—EGFR—melanoma	1.43e-05	0.00016	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—MAP2K1—melanoma	1.42e-05	0.000159	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—ABCB1—melanoma	1.42e-05	0.000159	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PIK3CD—melanoma	1.41e-05	0.000158	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PIK3CB—melanoma	1.4e-05	0.000156	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—PIK3CA—melanoma	1.4e-05	0.000156	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—MAP2K1—melanoma	1.39e-05	0.000155	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PTGS2—melanoma	1.39e-05	0.000155	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—KRAS—melanoma	1.38e-05	0.000154	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PIK3CD—melanoma	1.38e-05	0.000154	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—PIK3CA—melanoma	1.37e-05	0.000153	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—KRAS—melanoma	1.35e-05	0.000151	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—FGF2—melanoma	1.35e-05	0.000151	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—FGF2—melanoma	1.32e-05	0.000148	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PRKCA—melanoma	1.31e-05	0.000146	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ABCB1—melanoma	1.3e-05	0.000146	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—ERCC2—melanoma	1.29e-05	0.000145	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PRKCA—melanoma	1.27e-05	0.000142	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—PIK3CA—melanoma	1.27e-05	0.000142	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—MDM2—melanoma	1.26e-05	0.000141	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—ERCC2—melanoma	1.26e-05	0.000141	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—ERBB2—melanoma	1.25e-05	0.000139	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—PIK3CA—melanoma	1.24e-05	0.000139	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—MDM2—melanoma	1.24e-05	0.000138	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PIK3CB—melanoma	1.23e-05	0.000138	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—ERBB2—melanoma	1.22e-05	0.000136	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PTEN—melanoma	1.21e-05	0.000135	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PIK3CB—melanoma	1.2e-05	0.000135	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PRKCA—melanoma	1.2e-05	0.000134	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ERCC2—melanoma	1.19e-05	0.000133	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CXCL8—melanoma	1.18e-05	0.000132	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—HRAS—melanoma	1.17e-05	0.000131	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CXCL8—melanoma	1.16e-05	0.000129	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CDKN1B—melanoma	1.15e-05	0.000129	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—HRAS—melanoma	1.15e-05	0.000128	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—AKT1—melanoma	1.14e-05	0.000128	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CASP3—melanoma	1.13e-05	0.000126	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—IL2—melanoma	1.13e-05	0.000126	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CDKN1B—melanoma	1.13e-05	0.000126	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—IL6—melanoma	1.12e-05	0.000126	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—AKT1—melanoma	1.12e-05	0.000125	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CASP3—melanoma	1.11e-05	0.000124	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—IL2—melanoma	1.11e-05	0.000124	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CCND1—melanoma	1.1e-05	0.000123	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—IL6—melanoma	1.1e-05	0.000123	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CTNNB1—melanoma	1.09e-05	0.000122	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CCND1—melanoma	1.08e-05	0.00012	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.07e-05	0.00012	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—MMP9—melanoma	1.07e-05	0.00012	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CTNNB1—melanoma	1.07e-05	0.000119	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CDKN1A—melanoma	1.07e-05	0.000119	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PTEN—melanoma	1.06e-05	0.000119	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—NFKB1—melanoma	1.06e-05	0.000118	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—MMP9—melanoma	1.05e-05	0.000117	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CDKN1A—melanoma	1.04e-05	0.000116	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PTEN—melanoma	1.04e-05	0.000116	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—AKT1—melanoma	1.04e-05	0.000116	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—NFKB1—melanoma	1.03e-05	0.000116	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PIK3CG—melanoma	1.02e-05	0.000114	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—AKT1—melanoma	1.01e-05	0.000113	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PIK3CG—melanoma	9.98e-06	0.000112	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PPARG—melanoma	9.87e-06	0.00011	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PPARG—melanoma	9.63e-06	0.000108	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—VEGFA—melanoma	9.6e-06	0.000107	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—STAT3—melanoma	9.51e-06	0.000106	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—NRAS—melanoma	9.48e-06	0.000106	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PIK3CG—melanoma	9.4e-06	0.000105	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—VEGFA—melanoma	9.39e-06	0.000105	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—STAT3—melanoma	9.3e-06	0.000104	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—NRAS—melanoma	9.28e-06	0.000104	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—MAPK3—melanoma	9.08e-06	0.000102	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PPARG—melanoma	9.08e-06	0.000101	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PIK3CD—melanoma	8.99e-06	0.0001	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—MAPK3—melanoma	8.88e-06	9.93e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—ALB—melanoma	8.87e-06	9.92e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—MYC—melanoma	8.83e-06	9.87e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PIK3CD—melanoma	8.77e-06	9.81e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—ALB—melanoma	8.66e-06	9.68e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—MAPK1—melanoma	8.64e-06	9.66e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—MYC—melanoma	8.64e-06	9.66e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—EGFR—melanoma	8.64e-06	9.66e-05	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PIK3CA—melanoma	8.53e-06	9.54e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—MAPK1—melanoma	8.45e-06	9.45e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—EGFR—melanoma	8.45e-06	9.45e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PIK3CD—melanoma	8.27e-06	9.24e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—KRAS—melanoma	8.16e-06	9.12e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ALB—melanoma	8.16e-06	9.12e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—KRAS—melanoma	7.98e-06	8.93e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PIK3CB—melanoma	7.83e-06	8.76e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PTGS2—melanoma	7.76e-06	8.68e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PIK3CB—melanoma	7.65e-06	8.55e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PTGS2—melanoma	7.58e-06	8.47e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PIK3CA—melanoma	7.5e-06	8.38e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PIK3CA—melanoma	7.33e-06	8.2e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—TP53—melanoma	7.25e-06	8.11e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PIK3CB—melanoma	7.21e-06	8.06e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PTGS2—melanoma	7.14e-06	7.98e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—TP53—melanoma	7.1e-06	7.93e-05	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—AKT1—melanoma	6.97e-06	7.79e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—HRAS—melanoma	6.94e-06	7.76e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—HRAS—melanoma	6.79e-06	7.59e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PTEN—melanoma	6.77e-06	7.57e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—IL6—melanoma	6.64e-06	7.42e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PTEN—melanoma	6.61e-06	7.39e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—IL6—melanoma	6.5e-06	7.26e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PTEN—melanoma	6.23e-06	6.96e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—AKT1—melanoma	6.13e-06	6.85e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—AKT1—melanoma	5.99e-06	6.7e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PIK3CA—melanoma	4.78e-06	5.34e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PIK3CA—melanoma	4.66e-06	5.21e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PIK3CA—melanoma	4.39e-06	4.91e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—AKT1—melanoma	3.9e-06	4.36e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—AKT1—melanoma	3.81e-06	4.26e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—AKT1—melanoma	3.59e-06	4.01e-05	CbGpPWpGaD
